Navigation Links
Cambrex to Announce Fourth Quarter 2011 Financial Results on February 6, 2012
Date:2/2/2012

EAST RUTHERFORD, N.J., Feb. 2, 2012 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM) announced that fourth quarter 2011 financial results will be released on Monday, February 6, 2012 after the market closes.

The Company will host a conference call to discuss the fourth quarter 2011 financial results. 

Fourth Quarter 2011 Earnings Conference Call  When: 

Tuesday, February 7, 2012 at 8:30 a.m. Eastern Time  Dial-in:1-866-719-0110 for U.S. 

1-719-457-2697 for International  

Passcode:  4461870 Dial-in Replay:1-888-203-1112 for U.S. 

1-719-457-0820 for International 

Passcode:  4461870 

Available through Tuesday, February 14, 2012 Webcast:www.cambrex.com 

Available for 30 days following the conference callAbout Cambrex

Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  We offer Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products.  For more information, please visit www.cambrex.com.


'/>"/>
SOURCE Cambrex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Cambrex Reports Second Quarter of 2011 Results
2. Cambrex Reports Third Quarter 2010 Results
3. Cambrex Reports Fourth Quarter and Full Year 2009 Results
4. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Nominated for 2009 Innovations Award
5. Cambrex Reports First Quarter 2009 Results
6. Cambrex Receives Notice Regarding NYSE Listing
7. Cambrex Reports Third Quarter 2008 Results
8. Sangamo BioSciences Announces Fourth Quarter and Full Year 2011 Conference Call and Webcast
9. Generex Announces Patent Award for its Core Vaccine Technologies in Japan
10. Galien Foundation Announces 2012 Awards Program For Best Biopharmaceutical Products and Best Medical Technology
11. Soligenix Announces 1 for 20 Reverse-Split of its Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/14/2019)... , ... August 13, 2019 , ... ... and in vitro toxicology testing solutions, announced the appointment of Mark McLoughlin to ... to the Board. , Mark McLoughlin will lend his healthcare expertise and extensive ...
(Date:8/6/2019)... DIEGO (PRWEB) , ... August 06, 2019 , ... ... Marketing Radio (LSMR) have joined forces in launching the biweekly SDBN BUZZ podcast ... further growth. SDBN BUZZ podcast will also serve to promote the region and ...
(Date:8/4/2019)... MINNEAPOLIS (PRWEB) , ... August 02, 2019 , ... Cirtec ... minimally invasive devices, today announced that it has begun construction on a 30,000 sq. ... about 15 miles from San Jose. , The facility, which is expected to ...
(Date:7/19/2019)... , ... July 18, 2019 , ... ... announced their investment to enlarge their current piezo motion facilities in Lederhose, Germany, ... 3 floors for multilayer piezo ceramic assembly production in addition to general office ...
Breaking Biology Technology:
(Date:7/26/2019)... ... 2019 , ... Worldwide Business with kathy ireland® ... Deschamps to discuss their potential new treatment option to manage neurological symptoms of ... in the medical device industry that's focused on neurological wellness. With a sharp ...
(Date:7/24/2019)... ... 2019 , ... NDA Partners Chairman Carl Peck, MD ... than 20 years of experience working in scientific research and FDA-regulated environments including ... Expert Consultant. , Dr. Hartzfeld has experience in all aspects of quality, laboratory, ...
(Date:7/23/2019)... ... ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell company, has received ... adipose-derived stem cells to treat their osteoarthritis. The first clinical trial, expected to begin ... , This is the first of several planned clinical trials which will enable ...
Breaking Biology News(10 mins):